{"id":"W3090469545","doi":"10.1200/jco.20.00995","title":"Five-Year Outcomes With Nivolumab in Patients With Wild-Type <i>BRAF</i> Advanced Melanoma","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":227,"is_retracted":false,"has_abstract":true,"ca_institutions":"Royal Victoria Hospital; McGill University; University of British Columbia; BC Cancer Agency","funders":"Ono Pharmaceutical; Bristol-Myers Squibb","keywords":"Medicine; Nivolumab; Melanoma; Oncology; Internal medicine; Metastatic melanoma; Ipilimumab; Cancer research; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004175025,0.0001558307,0.0008010868,0.0000354453,0.00002284514,0.00000690355,0.0002565779,0.0002704643,0.00002644117],"category_scores_gemma":[0.0008369702,0.00009853877,0.000142632,0.0001150093,0.0001108397,0.00001261629,0.00007018324,0.0004309888,0.00001142241],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001920012,"about_ca_system_score_gemma":0.0006083183,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000476009,"about_ca_topic_score_gemma":0.00006093914,"domain_scores_codex":[0.9981381,0.0002073079,0.0009583982,0.0002508349,0.0002290319,0.000216357],"domain_scores_gemma":[0.9983197,0.0001366277,0.0008011399,0.0001742759,0.0002929824,0.0002752184],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01003486,0.0005988867,0.9760289,0.00001027206,0.0001768149,0.0001294032,0.00004564678,0.00009188448,0.0005786257,0.00002378343,0.001870942,0.01041001],"study_design_scores_gemma":[0.01859134,0.06070517,0.8515381,0.00002855975,0.00007131189,0.00001609894,0.00009100756,0.000006771865,0.0006033509,0.00002064313,0.06812043,0.0002072691],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966176,0.00008215188,0.0001055245,0.001378581,0.0003158374,0.0001427555,0.000005271531,0.00000396734,0.001348333],"genre_scores_gemma":[0.9930516,0.00006376246,0.003451429,0.002950782,0.0003257519,0.000001756003,0.0000135891,0.00002058591,0.0001207832],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1244908,"threshold_uncertainty_score":0.4018294,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02934943225884844,"score_gpt":0.3323646425640745,"score_spread":0.303015210305226,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}